Zutectra

Country: European Union

Language: Danish

Source: EMA (European Medicines Agency)

Buy It Now

Active ingredient:

human hepatitis B immunoglobulin

Available from:

Biotest Pharma GmbH

ATC code:

J06BB04

INN (International Name):

human hepatitis B immunoglobulin

Therapeutic group:

Immune sera og immunoglobuliner,

Therapeutic area:

Immunization, Passive; Hepatitis B; Liver Transplantation

Therapeutic indications:

Forebyggelse af hepatitis B virus (HBV) re-infektion hos HBsAg og HBV-DNA-negative voksne patienter mindst en uge efter levertransplantation for hepatitis B induceret leversvigt. HBV-DNA-negativ status bør bekræftes inden for de sidste 3 måneder før OLT. Patienterne bør være HBsAg-negative før behandlingen starter. Samtidig brug af passende virostatic agenter bør betragtes som standard for hepatitis B re-infektion profylakse.

Product summary:

Revision: 16

Authorization status:

autoriseret

Authorization date:

2009-11-30

Patient Information leaflet

                                504 ERROR
THE REQUEST COULD NOT BE SATISFIED.
-------------------------
CloudFront attempted to establish a connection with the origin, but
either the attempt failed or the origin closed the connection. We
can't connect to the server for this app or website at this time.
There might be too much traffic or a configuration error. Try again
later, or contact the app or website owner.
If you provide content to customers through CloudFront, you can find
steps to troubleshoot and help prevent this error by reviewing the
CloudFront documentation.
-------------------------
Generated by cloudfront (CloudFront)
Request ID: nfLydfwh80XUHwWatylYYzqFLmCtTubUxNXECD389zLOBN4aDbieXg==
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                504 ERROR
THE REQUEST COULD NOT BE SATISFIED.
-------------------------
CloudFront attempted to establish a connection with the origin, but
either the attempt failed or the origin closed the connection. We
can't connect to the server for this app or website at this time.
There might be too much traffic or a configuration error. Try again
later, or contact the app or website owner.
If you provide content to customers through CloudFront, you can find
steps to troubleshoot and help prevent this error by reviewing the
CloudFront documentation.
-------------------------
Generated by cloudfront (CloudFront)
Request ID: nfLydfwh80XUHwWatylYYzqFLmCtTubUxNXECD389zLOBN4aDbieXg==
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet Bulgarian 13-02-2024
Summary of Product characteristics Summary of Product characteristics Bulgarian 13-02-2024
Public Assessment Report Public Assessment Report Bulgarian 23-02-2016
Patient Information leaflet Patient Information leaflet Spanish 13-02-2024
Public Assessment Report Public Assessment Report Spanish 23-02-2016
Patient Information leaflet Patient Information leaflet Czech 13-02-2024
Public Assessment Report Public Assessment Report Czech 23-02-2016
Patient Information leaflet Patient Information leaflet German 13-02-2024
Public Assessment Report Public Assessment Report German 23-02-2016
Patient Information leaflet Patient Information leaflet Estonian 13-02-2024
Public Assessment Report Public Assessment Report Estonian 23-02-2016
Patient Information leaflet Patient Information leaflet Greek 13-02-2024
Public Assessment Report Public Assessment Report Greek 23-02-2016
Patient Information leaflet Patient Information leaflet English 13-02-2024
Public Assessment Report Public Assessment Report English 23-02-2016
Patient Information leaflet Patient Information leaflet French 13-02-2024
Public Assessment Report Public Assessment Report French 23-02-2016
Patient Information leaflet Patient Information leaflet Italian 13-02-2024
Public Assessment Report Public Assessment Report Italian 23-02-2016
Patient Information leaflet Patient Information leaflet Latvian 13-02-2024
Public Assessment Report Public Assessment Report Latvian 23-02-2016
Patient Information leaflet Patient Information leaflet Lithuanian 13-02-2024
Summary of Product characteristics Summary of Product characteristics Lithuanian 13-02-2024
Public Assessment Report Public Assessment Report Lithuanian 23-02-2016
Patient Information leaflet Patient Information leaflet Hungarian 13-02-2024
Summary of Product characteristics Summary of Product characteristics Hungarian 13-02-2024
Public Assessment Report Public Assessment Report Hungarian 23-02-2016
Patient Information leaflet Patient Information leaflet Maltese 13-02-2024
Public Assessment Report Public Assessment Report Maltese 23-02-2016
Patient Information leaflet Patient Information leaflet Dutch 13-02-2024
Public Assessment Report Public Assessment Report Dutch 23-02-2016
Patient Information leaflet Patient Information leaflet Polish 13-02-2024
Public Assessment Report Public Assessment Report Polish 23-02-2016
Patient Information leaflet Patient Information leaflet Portuguese 13-02-2024
Summary of Product characteristics Summary of Product characteristics Portuguese 13-02-2024
Public Assessment Report Public Assessment Report Portuguese 23-02-2016
Patient Information leaflet Patient Information leaflet Romanian 13-02-2024
Public Assessment Report Public Assessment Report Romanian 23-02-2016
Patient Information leaflet Patient Information leaflet Slovak 13-02-2024
Public Assessment Report Public Assessment Report Slovak 23-02-2016
Patient Information leaflet Patient Information leaflet Slovenian 13-02-2024
Summary of Product characteristics Summary of Product characteristics Slovenian 13-02-2024
Public Assessment Report Public Assessment Report Slovenian 23-02-2016
Patient Information leaflet Patient Information leaflet Finnish 13-02-2024
Public Assessment Report Public Assessment Report Finnish 23-02-2016
Patient Information leaflet Patient Information leaflet Swedish 13-02-2024
Public Assessment Report Public Assessment Report Swedish 23-02-2016
Patient Information leaflet Patient Information leaflet Norwegian 13-02-2024
Summary of Product characteristics Summary of Product characteristics Norwegian 13-02-2024
Patient Information leaflet Patient Information leaflet Icelandic 13-02-2024
Summary of Product characteristics Summary of Product characteristics Icelandic 13-02-2024
Patient Information leaflet Patient Information leaflet Croatian 13-02-2024
Public Assessment Report Public Assessment Report Croatian 23-02-2016

Search alerts related to this product

View documents history